The Latin America, Middle East and Africa Image-guided Therapy Systems Market would witness market growth of 6.3% CAGR during the forecast period (2022-2028).
The type of intervention, particularly between percutaneous, vascular, and open procedures, frequently affects the imaging requirements. These days, no one imaging study can cover all of the clinical needs for minimally invasive therapy. Due to MRI's greater specificity and sensitivity even in small lesions, it is often used as a guidance tool in percutaneous ablative therapy. However, quick, near-real-time imaging is also feasible with US and MRI, allowing percutaneous access to be made. However, employing CT fluoroscopy imaging can also provide quick and precise guidance, with the drawback of exposing the intervention list and the patient to radiation.
Planning the treatment and ensuring proper catheter positioning for intravascular therapies requires a precise understanding of the vascular anatomy for access routes and associated irregularities such as stenosis, occlusion, and tumor feeding vessels. This can typically be accomplished by 2D digital subtraction angiography. Recent developments in imaging technology create soft-tissue images that resemble CT scans, enabling the diagnosis of complex vascular conditions in well-equipped settings. However, considering the limited access, limited necessity, and associated high expenses, it is questionable if such procedures should be used in all hybrid operating rooms. In this situation, the best course of therapy and the least amount of money spent should take precedence.
The demand for CT devices in the local market is rising as a result of the government's growing investments in creating a strong healthcare infrastructure. The increased incidence of various disorders, including malignancies, dental issues, and others, will also boost demand for CT in this local market. More significant market participants are investing in this area and growing their businesses as a result of the untapped potential of this area. Additionally, consumer healthcare spending is rising, which is driving up the demand for the Image-guided Therapy Systems Market.
The Brazil market dominated the LAMEA Image-guided Therapy Systems Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $90.8 Million by 2028. The Argentina market is experiencing a CAGR of 6.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 6% during (2022 - 2028).
Based on Application, the market is segmented into Cardiac Surgery, Urology, Neurosurgery, Gastroenterology, Orthopedic Surgery, Oncology Surgery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research & Academic Institutions. Based on Product, the market is segmented into Endoscopes, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scanners, Ultrasound Systems, X-ray Fluoroscopy and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Image-guided Therapy Systems Market is Predict to reach $5.5 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Analogic Corporation, General Electric (GE) Co. (GE Healthcare), Brainlab AG, Olympus Corporation, and Stryker Corporation.
By Application
By End-Use
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
